RESEARCH TRIANGLE PARK – The longtime chief science and medical officer at ViiV Healthcare, which has a major presence, is stepping down in the near future.

John Pottage has been a fixture at ViiV since the company launched with a mission of combating HIV in 2009. The firm is majority owned by drug giant GlaxoSmithKline.

ViiV has developed a number of treatments that could help curb the AIDS menace.

Pottage will leave his roles by Oct. 1 and be replaced by Kimberly Smith and Harmony Garges, according to BiopharmaDive.

Smith is head of research. Garges leads medical affairs.

More ViiV headlines from TechWire

ViiV Healthcare’s HIV drug OK’d for European sales

Results of monthly shots to combat AIDS in trials boosts ViiV Healthcare’s combo treatment